Article

Five-year NIH grant to aid AMD research

The National Eye Institute of the National Institutes of Health has awarded a 5-year, $14.6 million grant to fund a study of age-related macular degeneration.

The National Eye Institute of the National Institutes of Health (NIH) has awarded a 5-year, $14.6 million grant to fund a study of age-related macular degeneration (AMD).

The grant will finance an international, interdisciplinary effort led by the University of Iowa to leverage two recent genetic discoveries into possible treatments for AMD.

Gregory Hageman, PhD, professor of ophthalmology and visual sciences at the University of Iowa Roy J. and Lucille A. Carver College of Medicine, will lead the multi-institutional effort.In the past year, the University of Iowa, Columbia University Medical Center, and the National Cancer Institute, along with others, determined that two genes -- those for complement factor H and factor B -- account for nearly three out of four cases of AMD.

The scientists will investigate the genes' role in the immune system, with the goal of developing diagnostic tools and treatment.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.